Cancer: is a disease in which abnormal cells divide uncontrollably and destroy body tissue. Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues.
-
Brain tumors are the leading cause of solid-tumor-related deaths among children. These tumors are now categorized by WHO as separated from adult brain tumors and based on their distinct mole...
NOV 13, 2024 | 9:00 AM
C.E. CREDITS
Cancer research is advancing rapidly, but the complexity of managing data, fostering collaboration, and optimizing workflows presents significant challenges to research teams. In this webina...
High resolution surveys of the tumor microenvironment (TME) are needed to obtain a holistic portrait of the genetic, epigenetic, and cellular factors contributing to cancer progression. To t...
Liquid biopsy next-generation sequencing (NGS) assays help guide treatment selection in cancer patients, particularly when tumor tissue is unavailable or during disease progression. Extensiv...
OCT 30, 2024 | 8:00 AM
C.E. CREDITS
Predicting patient outcomes in cancer treatment is key to creating personalized and effective therapeutic plans. Join Dr. Osman in this engaging webinar as she delves into the cutting-edge w...
Antibody–drug conjugates (ADC) are targeted therapies that are designed to deliver highly potent cytotoxic agents to specific tumor cells saving normal tissue. They combined a monoclon...
Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditi...
OCT 16, 2024 | 10:30 AM
C.E. CREDITS
The use of biologic-based therapeutics has revolutionized our ability to treat complex diseases such as cancer- and autoimmune-related disorders. Biologic-based therapeutics are known to gen...
OCT 16, 2024 | 7:30 AM
C.E. CREDITS
Across the entire spectrum of the life sciences sector, from academia and hospitals to pharmaceutical and biotech companies, enormous amounts of resources are invested in the development of...
The path from research discovery to effective immune cell therapies requires innovative approaches to match the challenges we face. Examining the full richness of biological complexity&mdash...
Discover how targeting RNA-binding motif protein 39 (RBM39) is unlocking new possibilities in cancer treatment. RBM39, a key player in transcriptional regulation, alternative splicing, and p...
October 15, 2024 | 7:00am PDT, 9:00am CDT, 10:00am EDT
Advancements in spatial proteomic workflows, featuring enzyme-activated spatial amplification reagents, have revolutionized cancer research capabilities. This webinar will include an explana...
OCT 02, 2024 | 2:00 PM
C.E. CREDITS
Learning Objectives 1. Discuss Neoantigen Mechanisms: Gain a comprehensive understanding of the mechanisms by which neoantigens are generated and recognized by the immune system, including t...